NEW YORK (GenomeWeb News) – Life Biosystems will use Temis’ text mining software for analyzing clinical and molecular data from a variety of textual information sources, Temis said today.
 
Life Biosystems, which uses patient information and molecular data to develop predictive medicine products, will use Temis’ Luxid software to analyze molecular information under a new software and services agreement, Temis said.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.